Antiretroviral drug toxicity -- a challenge for the hepatologist?
about
Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine.Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection.Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected personsCoinfection with HIV and hepatitis C virus in injection drug users and minority populations.Treatment of hepatitis C in HIV-coinfected patients.Review of tenofovir-emtricitabine.Management of hepatic complications in HIV-infected persons.Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors.Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver disease.Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy.Studies on the toxicological effect of nevirapine, an antiretroviral drug, on the liver, kidney and testis of male Wistar rats.Detection of Adverse Drug Reaction Signals in the Thai FDA Database: Comparison between Reporting Odds Ratio and Bayesian Confidence Propagation Neural Network Methods
P2860
Q34794696-42019251-FCE8-47A9-AE96-3F76A5600C6FQ34998102-9CC0023E-1A17-4D13-A2D2-6A3452877FD1Q35062602-CF5E6288-3A64-46BF-880D-CC7683AF5C83Q36304424-CFBCDC14-C871-4912-B6AF-C0FCADA3CA64Q36409500-015F84B6-3779-4B72-83E2-99B21D37B7D1Q36663686-16BC4294-8396-4497-A8DD-159C1E84DC30Q37151303-33DD9C99-1568-493C-A38F-F0FCE7B29EE8Q39997145-B54157BE-6278-4F33-9237-16B0956EEC83Q40271245-9411BB91-03C0-4AC0-84BC-811D5EE5E376Q44778139-4203BD30-22D7-44D9-AB21-C9EE184593C4Q45474051-C310BBFE-9572-4FBB-92ED-26035BD66EB1Q46907929-748AF37E-6C0F-4877-8E87-4F9503B4A40CQ50593950-93032414-8275-4133-8446-56B0D55F9CD9Q57175680-EB92AD5E-AC46-497B-B322-2EB6028D24AA
P2860
Antiretroviral drug toxicity -- a challenge for the hepatologist?
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@ast
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@en
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@nl
type
label
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@ast
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@en
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@nl
prefLabel
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@ast
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@en
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@nl
P2093
P1476
Antiretroviral drug toxicity -- a challenge for the hepatologist?
@en
P2093
Jürgen Kurt Rockstroh
Mathias Lichterfeld
Ulrich Spengler
P304
P356
10.1016/S0168-8278(01)00311-7
P577
2002-02-01T00:00:00Z